HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary neutrophil-rich, CD30-positive anaplastic large cell lymphoma of the stomach: case report and review of the literature.

Abstract
Primary T-cell lymphoma of the stomach is a rare disease, most gastric lymphomas being of B-cell type. Here we describe a unique case of primary neutrophil-rich CD30-positive anaplastic large cell lymphoma (ALCL) of the stomach that was treated and cured by combined chemotherapy. According to our literature review, only 7 cases of primary gastric ALCL have been previously reported, none of them being of the neutrophil-rich subtype. Although very peculiar in its histological presentation, which may simulate an inflammatory or carcinomatous process, the natural history as well as the clinical features of this unusual gastric lymphoma does not differ from the other reported cases of gastric ALCL.
AuthorsM Kahaleh, P Hermans, M Buset, J L Dargent
JournalActa gastro-enterologica Belgica (Acta Gastroenterol Belg) 2002 Oct-Dec Vol. 65 Issue 4 Pg. 237-40 ISSN: 1784-3227 [Print] Belgium
PMID12619433 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Ki-1 Antigen
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
Topics
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Humans
  • Ki-1 Antigen (analysis)
  • Lymphoma, Large-Cell, Anaplastic (drug therapy, pathology)
  • Male
  • Middle Aged
  • Neutrophils (immunology, pathology)
  • Stomach Neoplasms (drug therapy, pathology)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: